Navigation Links
Medarex Announces Allowance of Investigational New Drug Application for Wholly-Owned Fully Human Anti-CXCR4 Antibody, MDX-1338
Date:5/27/2009

rm 10-Q. There can be no assurance that such development efforts will succeed or that developed products will receive required regulatory clearance or that, even if such regulatory clearance were received, such products would ultimately achieve commercial success. Copies of Medarex's public disclosure filings are available from its investor relations department.

Medarex(R), the Medarex logo and UltiMAb(R) are registered trademarks of Medarex, Inc. All rights are reserved.


'/>"/>
SOURCE Medarex, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Medarex Announces Primary Endpoint Achieved in MDX-1100 Anti-IP-10 Antibody Phase 2 Trial for Rheumatoid Arthritis
2. Medarex Announces Preclinical Data from Multiple Research Programs Demonstrating Anti-Tumor Activity in Cancer
3. Medarex Announces Enhanced Activity Data with Second Generation Anti-CD30 Antibody for Malignant Lymphoma
4. Medarex Announces Initiation of Phase 1b Clinical Development Program with MDX-1106 for the Treatment of Cancer
5. Medarex Receives Milestone Payment for Investigational Antibody Targeting Integrin Receptors
6. Medarex Receives Milestone Payment from Pfizer for Investigational New Drug Application Filing
7. Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology
8. Medarex Announces Initiation of Phase 2 Clinical Development Program for the Treatment of Lupus
9. Medarex Announces Allowance of Investigational New Drug Application for Wholly-Owned Fully Human Anti-PD-L1 Antibody, MDX-1105
10. Medarex Highlights Strength in Antibody Development and Underlying Pipeline Strategy at R&D Day Event in New York City
11. Medarex Announces Initiation of Phase 2 Clinical Trials for the Treatment of Ulcerative Colitis and Rheumatoid Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... DIEGO , May 26, 2015 ... a clinical-stage biopharmaceutical company leveraging its molecular adhesion ... therapies for sickle cell disease, heart failure, and ... an open-label, multicenter Phase 3 extension study of ... as "EPIC-E."  The study will enroll patients who ...
(Date:5/26/2015)... , May 26, 2015  Accuray Incorporated (Nasdaq: ... is scheduled to present at the Jefferies 2015 Healthcare ... Wednesday, June 3, 2015 at 2:30pm ET.   ... available on the Investor Relations page of the Company,s ... the presentation will begin approximately one hour after the ...
(Date:5/26/2015)... 26, 2015 Egalet Corporation (Nasdaq: ... company focused on developing, manufacturing and marketing innovative ... , president and chief executive officer, is scheduled ... will provide an update on Egalet,s marketed product ... Spray, approved product OXAYDO ™ (oxycodone HCI, ...
Breaking Medicine Technology:Mast Therapeutics Announces Initiation Of EPIC-E Study 2Mast Therapeutics Announces Initiation Of EPIC-E Study 3Mast Therapeutics Announces Initiation Of EPIC-E Study 4Mast Therapeutics Announces Initiation Of EPIC-E Study 5Egalet to Present at Upcoming Conferences in June 2Egalet to Present at Upcoming Conferences in June 3
... 2, 2011 Aoxing Pharmaceutical (NYSE Amex: ... company focusing on research, development, manufacturing and distribution ... operating subsidiary in China, Hebei Aoxing Pharmaceutical Group ... State Intellectual Property Office of The People,s Republic ...
... TARRYTOWN, N.Y., May 2, 2011 Regeneron Pharmaceuticals, Inc. (Nasdaq: ... of America Merrill Lynch 2011 Health Care Conference on Tuesday, ... Eastern Time).  The session may be accessed through the Company,s ...  An archived version of the presentation will be available after ...
Cached Medicine Technology:Aoxing Pharmaceutical Company Announces Issuance of Chinese Patent for Naloxone Sublingual Film 2Aoxing Pharmaceutical Company Announces Issuance of Chinese Patent for Naloxone Sublingual Film 3
(Date:5/26/2015)... 3,000 senior industry executives are expected at ... future of the connected car. A very special attraction ... can read a driver’s brain waves. Visitors to its ... by mind alone just by gripping the steering wheel! ... are working on cognitive load, altering music based on ...
(Date:5/26/2015)... CO (PRWEB) May 26, 2015 It ... diverse community foundation in Colorado. On Wednesday, May 13, ... ushered in a new era of community-based giving with ... Titled “Our Future in the Making,” the event celebrated ... The Denver Foundation to mobilize resources for good. , ...
(Date:5/26/2015)... On May 26, 2015, My Positive Perspective ... distributor Dwayne Windfall. At the start of the episode, Deierlein ... some unique characteristics with it, so could you tell people ... saying, “I was reading the newspaper looking for a job ... looking for a person with hustle. I responded to the ...
(Date:5/26/2015)... Allprovide, the all-natural raw pet food company, today ... now available in three Georgia stores: Pooch-n-Paws in Suwannee; ... Dog Company in Kennesaw. , Allprovide is based out ... climate controlled facility. The fresh ingredients come from select ... food is triple-tested for quality. Unlike most pet foods, ...
(Date:5/26/2015)... CIO Review has chosen SIGNiX for its ... Technology Solution Providers. The positioning is based on an evaluation ... applicable across the entire security spectrum of transactions within life ... , “SIGNiX has been on our radar for some time ... Technology space, and we are happy to showcase them this ...
Breaking Medicine News(10 mins):Health News:The World’s Biggest Connected Car Exhibition is Back in Detroit 2Health News:The World’s Biggest Connected Car Exhibition is Back in Detroit 3Health News:Celebrating "Our Future in the Making" 2Health News:Celebrating "Our Future in the Making" 3Health News:My Positive Perspective Broadcasts Episode with Oceans 6 to Discuss Their Role in Helping the Community 2Health News:Allprovide, the All-Natural Pet Food, Available At Georgia Retailers 2Health News:CIO Review Selects SIGNiX as a 20 Most Promising Pharma and Life Sciences Technology Solution Provider in 2015 2Health News:CIO Review Selects SIGNiX as a 20 Most Promising Pharma and Life Sciences Technology Solution Provider in 2015 3
... from eating fish to krill (shrimp-like marine invertebrate animals) ... and whales, ancient eggshell fragments reveal. ... Carolina in Wilmington, and William Patterson of the University ... removed krill-eating predators, the penguins exploited the resulting shrimp ...
... time, researchers have shown that plant growth is regulated ... ,Using time-lapse photography, post-doctoral researcher Kazunari Nozue, ... the University of Lausanne, Switzerland, found that the shoots ... a day. They claimed that the timing of that ...
... first after restoring the fertility of a woman made ... ,The gynaecologist, Jacques Donnez, said he had successfully ... at the Cliniques Universitaires Saint-Luc in Brussels. ... graft, the patient continues to menstruate regularly. Her ovarian ...
... the stone that kills two vices. ,United States FDA-approved smoking ... handed out to alcoholics as well . , The ... used quite successfully by smokers , was tested to reveal the ... ,Says Selena Bartlett, a University of California, San Francisco ...
... ESMO Conference Lugano this week show that the drug, ... a marker of cancer activity, and shrank tumors in ... also in patients who had previously been treated with ... have continued to grow despite medical or surgical castration, ...
... in the July issue of the journal Cancer Cell, ... in development of acute promyelocytic leukemia (APL) and identifies ... its variant forms. ,Results from two new ... events that cause a deadly type of leukemia.,APL is ...
Cached Medicine News:Health News:Penguins Altered Diet When Humans Began Hunting Whales and Seals 2Health News:Two In One Drug For Smokers And Drinkers 2Health News:Hormone Inhibitor in Prostate Cancer Treatment 2Health News:Insights into Acute Promyelocytic Leukemia 2Health News:Insights into Acute Promyelocytic Leukemia 3
Non-reflective black anodized aluminum. Selection of five pin hole sizes (0.8 mm to 1.5 mm). Overall length: 4.0 inches....
4 mm x 4 mm downward biting jaws, curved right, length of shaft 115 mm, overall length 9.3 inches....
Right side cutting....
20 mm. Plastic, methylmethacrylate. Supplied sterile....
Medicine Products: